Role of liver transplantation for hepatobiliary malignant disorders

被引:19
作者
Marsh, JW [1 ]
Geller, DA [1 ]
Finkelstein, SD [1 ]
Donaldson, JB [1 ]
Dvorchik, I [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA
关键词
D O I
10.1016/S1470-2045(04)01527-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of liver transplantation for hepatobiliary malignant disorders remains controversial and will remain so until several crucial issues are resolved, the main difficulty being the shortage of organ donors. Furthermore, a consensus needs to be reached within the transplantation community on the tumour stage at which each disorder is too advanced to be salvaged by liver transplantation. Despite these limitations, there are generally accepted criteria that define when transplantation can, and should, be offered for hepatobiliary malignant disorders.
引用
收藏
页码:480 / 488
页数:9
相关论文
共 59 条
[21]   Living-donor liver transplantation for hepatocellular carcinoma [J].
Kaihara, S ;
Kiuchi, T ;
Ueda, M ;
Oike, F ;
Fujimoto, Y ;
Ogawa, K ;
Kozaki, K ;
Tanaka, K .
TRANSPLANTATION, 2003, 75 (03) :S37-S40
[22]   Liver transplantation for hepatocellular carcinoma - A registry report of the impact of tumor characteristics on outcome [J].
Klintmalm, GB .
ANNALS OF SURGERY, 1998, 228 (04) :479-488
[23]   Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations [J].
Libbrecht, L ;
Bielen, D ;
Verslype, C ;
Vanbeckevoort, D ;
Pirenne, J ;
Nevens, F ;
Desmet, V ;
Roskams, T .
LIVER TRANSPLANTATION, 2002, 8 (09) :749-761
[24]   Liver transplantation for small hepatocellular carcinoma:: The tumor-node-metastasis classification does not have prognostic power [J].
Llovet, JM ;
Bruix, J ;
Fuster, J ;
Castells, A ;
Garcia-Valdecasas, JC ;
Grande, L ;
Franca, A ;
Brú, C ;
Navasa, M ;
Ayuso, MD ;
Solé, M ;
Real, MI ;
Vilana, R ;
Rimola, A ;
Visa, J ;
Rodés, J .
HEPATOLOGY, 1998, 27 (06) :1572-1577
[25]   Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis [J].
Majno, PE ;
Adam, R ;
Bismuth, H ;
Castaing, D ;
Ariche, A ;
Krissat, J ;
Perin, H ;
Azoulay, D .
ANNALS OF SURGERY, 1997, 226 (06) :688-701
[26]  
Makhlouf HR, 1999, CANCER, V85, P562, DOI 10.1002/(SICI)1097-0142(19990201)85:3<562::AID-CNCR7>3.0.CO
[27]  
2-T
[28]   Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival [J].
Marsh, JW ;
Finkelstein, SD ;
Demetris, AJ ;
Swalsky, PA ;
Sasatomi, E ;
Bandos, A ;
Subotin, M ;
Dvorchik, I .
LIVER TRANSPLANTATION, 2003, 9 (07) :664-671
[29]  
Marsh JW, 2000, CANCER, V88, P538, DOI 10.1002/(SICI)1097-0142(20000201)88:3<538::AID-CNCR7>3.0.CO
[30]  
2-H